Simultaneous determination of ketobemidone and its N-demethylated metabolite in patient plasma samples by gas chromatography mass spectrometry with selected ion monitoring.
An analytical procedure has been developed for the simultaneous determination of ketobemidone and its N-demethylated metabolite, norketobemidone. After isolation from plasma and re-extraction to acidic aqueous phase, the two aminophenols were extracted as ions pairs with tetrabutylammonium to dichloromethane, where derivatization with ethyl chloroformate took place. Determination was performed by gas chromatography mass spectrometry with selected ion monitoring. Ketobemidone and norketobemidone could be detected in plasma in a concentration of 1 ng ml-1 and 3 ng ml-1, respectively. Determinations were performed down to 5 ng ml-1. The relative standard deviation of the method in the analysis of 10 ng ml-1 of ketobemidone and norketobemidone, respectively, was 8% and 9% (n=10). The absolute recovery of unconjugated ketobemidone and norketobemidone through the method at the 100 ng ml-1 level was 91% and 85%, respectively. The method was applied to the determination of ketobemidone and norketobemidone in plasma from patients given ketobemidone. The concentrations of unconjugated norketobemidone was too small to be detected.
D000701:Analgesics, Opioid / Q000097:blood*; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007477:Ions; D007540:Isonipecotic Acids / Q000097:blood*; D008614:Meperidine / Q000031:analogs & derivatives* / Q000097:blood; D010636:Phenols / Q000097:blood*
D000701:Analgesics, Opioid; D007477:Ions; D007540:Isonipecotic Acids; D010636:Phenols; C011044:norketobemidone; D008614:Meperidine; C012394:ketobemidone